지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.1
- 수록면
- 18 - 24 (7page)
- DOI
- 10.3349/ymj.2022.0455
이용수
초록· 키워드
오류제보하기
Purpose: Advanced chronic kidney disease (CKD), including end-stage renal disease (ESRD) on dialysis, increases thromboem bolic risk among patients with atrial fibrillation (AF). This study examined the comparative safety and efficacy of direct-acting oral anticoagulant (DOAC) compared to warfarin or no oral anticoagulant (OAC) in AF patients with advanced CKD or ESRD on dialysis.
Materials and Methods: Using data from the COmparison study of Drugs for symptom control and complication prEvention of AF (CODE-AF) registry, 260 non-valvular AF patients with advanced CKD (defined as estimated glomerular filtration rate <30 mL/min per 1.73/m2) or ESRD on dialysis were enrolled from June 2016 to July 2020. The study population was categorized into DOAC, warfarin, and no OAC groups; and differences in major or clinically relevant non-major (CRNM) bleeding, stroke/systemic embolism (SE), myocardial infarction/critical limb ischemia (CLI), and death were assessed.
Results: During a median 24 months of follow-up, major or CRNM bleeding risk was significantly reduced in the DOAC group compared to the warfarin group [hazard ratio (HR) 0.11, 95% confidence interval (CI) 0.01 to 0.93, p=0.043]. In addition, the risk of composite adverse clinical outcomes (major or CRNM bleeding, stroke/SE, myocardial infarction/CLI, and death) was significantly reduced in the DOAC group compared to the no OAC group (HR 0.16, 95% CI 0.03 to 0.91, p=0.039).
Conclusion: Among AF patients with advanced CKD or ESRD on dialysis, DOAC was associated with a lower risk of major or CRNM bleeding compared to warfarin and a lower risk of composite adverse clinical outcomes compared to no OAC.
ClinicalTrials.gov (NCT02786095)
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Safety and effectiveness of direct oral anticoagulants in fragile patients with venous thromboembolism: a retrospective cohort observational study
Annals of Surgical Treatment and Research
2025 .03
-
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
대한뇌졸중학회지
2020 .01
-
2018 대한부정맥학회 심방세동 환자에서 항응고제의 적합한선택 및 용량 권고안: 특수 상황과 고위험군 환자
대한내과학회지
2018 .01
-
심방세동과 말기 콩팥병이 동반된 환자에서 와파린과 항혈소판 요법의 안전성과 효과 비교
대한내과학회지
2019 .04
-
Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
Korean Circulation Journal
2018 .01
-
Clinical outcomes among hemodialysis patients with atrial fibrillation: a Korean nationwide population-based study
Kidney Research and Clinical Practice
2021 .01
-
2021 대한부정맥학회 심방세동 환자의 뇌졸중 예방 관리 지침
대한내과학회지
2021 .08
-
비판막성심방세동 환자에서 직접작용 경구용 항응고제 임상적 효과와 부작용 연구
한국임상약학회지
2022 .03
-
Prevalence of Atrial Fibrillation in Korean Population
International Journal of Arrhythmia
2017 .12
-
Bleeding after Endoscopic Resection in Patients with End-Stage Renal Disease on Dialysis: A Multicenter Propensity Score-Matched Analysis
Clinical Endoscopy
2020 .01
-
Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
뇌신경재활
2021 .11
-
2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침
대한내과학회지
2018 .01
-
Real-World Risk of Gastrointestinal Bleeding for Direct Oral Anticoagulants and Warfarin Users: A Distributed Network Analysis Using a Common Data Model
Gut and Liver
2024 .09
-
Optimal Dose of Edoxaban for Very Elderly Atrial Fibrillation Patients at High Risk of Bleeding: The LEDIOS Registry
Korean Circulation Journal
2024 .07
-
만성신장병환자에서 apixaban과 warfarin의 안전성 비교: 체계적 문헌고찰 및 메타분석
한국임상약학회지
2021 .01
-
Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal
Korean Circulation Journal
2019 .01
-
Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants
Korean Circulation Journal
2022 .08
-
Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
Korean Circulation Journal
2018 .01
-
Risk Factor Management for Atrial Fibrillation
Korean Circulation Journal
2019 .01
-
Chronic Obstructive Pulmonary Disease Increases the Risk of New-onset Atrial Fibrillation and Mortality of Patients with Atrial Fibrillation
International Journal of Arrhythmia
2017 .12
이 논문의 저자 정보
최근 본 자료
댓글(0)
0